Huadong Medicine Co. Ltd. (SZSE:000963) said unit and partners plan to invest a combined CNY 300 million ($41.16 million) for 8.6% stake in pharmaceutical firm.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.88 CNY | 0.00% | +2.85% | -18.28% |
Apr. 25 | Huadong Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Huadong Medicine's 2023 Profit Jumps 14% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.28% | 8.22B | |
+17.88% | 71.72B | |
-1.07% | 24.29B | |
+8.01% | 8.31B | |
+1.47% | 8.16B | |
+4.03% | 4.76B | |
+16.55% | 4.31B | |
-0.70% | 4.1B | |
-2.47% | 3.91B | |
+26.24% | 3.78B |
- Stock Market
- Equities
- 000963 Stock
- News Huadong Medicine Co., Ltd
- Huadong Medicine's Unit, Partners to Invest in Pharmaceutical Firm